What is the AVTE stock price prediction for next 2 weeks?

According to our price prediction algorithm,Aerovate Therapeutics, Inc. (AVTE) price will be around $2.81 in the next 2 weeks. This means it will increase by 4.850746268656712 from the last closing price. This prediction may vary from other time period filters for AVTE stock.

What can be the highest Possible price of AVTE stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, AVTE can achieve the highest price of $2.87 which is 7.0804056176904355 higher than last closing price. This prediction may vary from other time period filters for AVTE stock.

What can be the lowest Possible price of AVTE stock in next 2 weeks?

As per the forecast and algorithmic analysis, AVTE stock price can be as low as $2.75 which is 2.693338343696224 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for AVTE stock.

Will AVTE stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that AVTE stock will gain4.850746268656712 in the next 2 weeks. This prediction may vary from other time period filters for AVTE stock.

What is AVTE stock last closing price?

Last closing price of AVTE stock was $93.80.

What is AVTE stock price prediction?

AVTE stock price prediction means predicting the future closing prices of AVTE stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of AVTE stock in a certain time period.

How we predict AVTE stock future prices?

If you are searching for AVTE stock forecast, analysis or price prediction, then you might be wondering what Aerovate Therapeutics, Inc. (AVTE) will do in the future. Our AVTE price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This AVTE price prediction will likely answer most of your questions.

How frequent we update AVTE stock predictions?

We are updating the forecasts for the AVTE stock on daily basis.

Is using ML forecasting for AVTE stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for AVTE stock same for all the time periods?

No, the prediction for AVTE stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Aerovate Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$93.800%Since 2 Weeks

Predicted Price$2.814.85%For 2 Weeks

Upper Predicted Price$2.877.08%For 2 Weeks

Lower Predicted Price$2.752.69%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of AVTE will rise by +4.85% over the next 2 Weeks and hit $2.81 by Monday, May 12, 2025. In that time frame, AVTE's share price is expected to range between $2.75 and $2.87.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 12, 2025	95.76	97.76	99.87
May 9, 2025	95.41	97.24	99.25
May 8, 2025	95.41	97.31	99.19
May 7, 2025	95.13	96.82	98.62
May 6, 2025	95.26	97.02	98.68
May 5, 2025	95.27	96.83	98.37
May 2, 2025	94.78	96.30	97.89
May 1, 2025	94.85	96.37	97.83
Apr 30, 2025	94.27	95.89	97.36
Apr 29, 2025	94.49	96.09	97.52

AVTE shares remained flat 0 in Monday, April 28, 2025's trading session, starting and closing at a previous close of $2.68 to move at $2.68. The stock demonstrated notable intraday movement (see AVTE's key stats for a full breakdown), fluctuating between $2.63 and $2.77, a +5.34% trading range. While recent weeks have seen some volatility, AVTE has managed to secure a -97.17% drop over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 29.13K shares changing hands, 2.08K fewer than the previous session. This amounted to $78.08K in total market activity.

Will AVTE Continue Its Upward Trend?

According to analyst ratings and projections for AVTE, Aerovate Therapeutics, Inc. shares are anticipated to increase by +97.32%, potentially reaching $99.87 per share by May 12, 2025. Short-term technical indicators currently suggest a neutral sentiment for AVTE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the AVTE stock forecast, now is a good time to buy AVTE stock because its current trading price is -97.26% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on AVTE covering social and institutional perspectives.

AVTE Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into AVTE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.17% to 58.33%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.44%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.14%, maintains a neutral outlook for the long term. Insights into AVTE's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Aerovate Therapeutics Short-Term Forecasts

AVTE Forecast For Next 5 Days

Our algorithm anticipates Aerovate Therapeutics (AVTE) stock could hit $94.26 by May 23, 2025. This represents a +3,417.03% fall from today's price, following a -3.25% change over the past five days.

AVTE Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Aerovate Therapeutics, Inc. (AVTE) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $92.18, which would mean a +3,339.55% increase from the current price of $2.68. Projections for this period range from a high of $97.46 to a low of $86.70.

AVTE Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Aerovate Therapeutics's price over the next three months point to a rise. AVTE stock is expected to peak at $202.52 on Jan 30, 2026 before potentially dipping to $0.00 on Apr 10, 2026. On average, AVTE is likely to trade around $37.57 in the coming 90 days.

Aerovate Therapeutics Stock Forecast 2025

Based on our predictive models, Aerovate Therapeutics (AVTE) is expected to trade between $0.00 and $202.52 throughout 2026. This would result in an average price of $42.82, potentially offering investors a +1,497.76% return from current levels.

Aerovate Therapeutics, Inc. Monthly Forecast 2025–2026

May 2025

According to our latest forecast models, Aerovate Therapeutics, Inc. (AVTE) is positioned to show a strong performance in May 2025. The price is predicted to move between $55.10 and $318.32, settling at an average of $175.12. This could translate to a +6,434.33% gain.

June 2025

Based on current market signals, Aerovate Therapeutics, Inc. is projected to trend june 2025. We forecast a trading range from $59.55 to $296.58, with a likely average price of $184.15. Investors could expect a potential return of +6,771.27%.

July 2025

Our predictive algorithms indicate Aerovate Therapeutics, Inc. stock may see a shift in July 2025. The expected range spans $76.03–$288.26, with an average target of $186.01. This represents a positive outlook and a possible gain of +6,840.67%.

August 2025

Analyzing established trends, Aerovate Therapeutics, Inc. looks set to move in August 2025. Projections place the stock between $40.15 and $271.68, averaging around $157.01. This suggests a +5,758.58% gain from current levels.

September 2025

Market indicators suggest Aerovate Therapeutics, Inc. could experience notable changes during September 2025. Prices could fluctuate within $0.00 to $276.65, with a midpoint forecast of $102.67. The stock might deliver a +3,730.97% gain.

October 2025

Forecasting for October 2025, models estimate that Aerovate Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $231.44, averaging $98.43. This signals a positive trajectory with potential returns around +3,572.76%.

November 2025

According to our latest forecast models, Aerovate Therapeutics, Inc. (AVTE) is positioned to show a strong performance in November 2025. The price is predicted to move between $0.00 and $228.12, settling at an average of $106.88. This could translate to a +3,888.06% gain.

December 2025

Based on current market signals, Aerovate Therapeutics, Inc. is projected to trend december 2025. We forecast a trading range from $0.00 to $208.55, with a likely average price of $109.00. Investors could expect a potential return of +3,967.16%.

January 2026

Our predictive algorithms indicate Aerovate Therapeutics, Inc. stock may see a shift in January 2026. The expected range spans $0.00–$202.52, with an average target of $83.32. This represents a positive outlook and a possible gain of +3,008.96%.

February 2026

Analyzing established trends, Aerovate Therapeutics, Inc. looks set to move in February 2026. Projections place the stock between $0.00 and $177.35, averaging around $21.12. This suggests a +688.06% gain from current levels.

March 2026

Market indicators suggest Aerovate Therapeutics, Inc. could experience notable changes during March 2026. Prices could fluctuate within $0.00 to $169.31, with a midpoint forecast of $29.01. The stock might deliver a +982.46% gain.

April 2026

Forecasting for April 2026, models estimate that Aerovate Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $161.56, averaging $35.17. This signals a positive trajectory with potential returns around +1,212.31%.

AVTE's history of dividends and stock splits also plays a role in long-term investor confidence.